Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Sionna Therapeutics, Inc.
AI Executive Summary
AI-powered analysis of 8-K filing content
Sionna Therapeutics held its Annual Meeting of Stockholders on June 17, 2026, electing four Class II directors to its board. This routine governance event reflects the company's leadership renewal process and establishes the board composition that will guide strategic direction through the next annual meeting.
Key Takeaways
Four Class II directors were elected: H. Edward Fleming Jr., M.D., Marcella Kuhlman Ruddy, M.D., Peter A. Thompson, M.D., and Joanne Louise Viney, Ph.D.
The meeting achieved quorum with 45,142,330 shares outstanding as of the April 21, 2026 record date
2 more takeaways